LOSARTAN DOES NOT IMPROVE LYMPHATIC TISSUE FIBROSIS OR T-CELL RECOVERY IN HIV
Incomplete immune recovery despite HIV viral suppression is associated with excess clinical risk, and is, in part a consequence of fibrosis within secondary lymphoid tissues. We hypothesized that the angiotensin receptor blocker losartan would inhibit fibrosis and improve T-cell recovery within lymphatic tissue, given its established effects in blocking TGF-b. We pooled data from two…